文献速递角膜与眼表疾病

基于失巢凋亡相关基因表达鉴定圆锥角膜分子亚型并预测潜在药物

Molecular Subtype Identification and Potential Drug Prediction Based on Anoikis-Related Genes Expression in Keratoconus.
PubMed 文献 · Invest Ophthalmol Vis Sci · 2025-01-01

研究分析圆锥角膜样本中失巢凋亡相关基因表达谱,鉴定差异表达基因,基于最佳聚类K识别两种分子亚型并比较功能与免疫特征,构建加权基因共表达网络获得枢纽基因及蛋白互作网络,预测胰岛素和地塞米松为潜在靶向药物。

要点

  • 圆锥角膜与正常样本间BCL2、CAV1、CEACAM5等失巢凋亡相关基因存在显著差异表达。
  • 基于失巢凋亡相关基因表达差异识别出两种明确分子亚型,其生物学功能与免疫浸润特征显著不同。
  • 共表达网络筛选出5202个枢纽基因,与显著差异表达基因取交集获得321个枢纽差异表达基因。

核心结论

  • 研究揭示了圆锥角膜样本中失巢凋亡相关基因的差异表达,并鉴定出在生物学功能和免疫浸润上显著不同的两种亚型。
  • 枢纽基因节点的鉴定阐明了其在预测潜在药物上的治疗价值。

研究设计与样本

  • 研究基于圆锥角膜数据集失巢凋亡相关基因表达谱,采用最佳聚类K鉴定分子亚型,并分析功能与免疫特征差异。
  • 基于聚类分析构建加权基因共表达网络获取枢纽基因,并构建蛋白互作网络分析枢纽节点、预测潜在节点靶向药物。

主要发现

  • 疾病与正常样本比较发现BCL2、CAV1、CEACAM5等失巢凋亡相关基因存在显著差异。
  • 京都基因与基因组百科全书和基因本体富集分析显示差异表达基因显著富集于ECM受体相互作用、趋化因子信号、notch信号、黏着斑等通路,以及蛋白水解、失巢凋亡、自然杀伤细胞和T细胞增殖调控等功能集。
  • CIBERSORT计算显示两种亚型在免疫细胞浸润(单核细胞和浆细胞)及免疫分子(CCL11、CCL14、HLA-A、HLA-B等)上存在显著差异。
  • 基于聚类表型构建共表达网络,筛选5202个基因作为枢纽基因,与显著差异表达基因取交集后获得321个枢纽差异表达基因。
  • 鉴定出EIF4G1、KHSRP、PABPC1、POLR2A、PTBP1、RPS19和SMARCA4共7个枢纽节点,并匹配药物或小分子化合物,胰岛素和地塞米松被鉴定为潜在靶向药物。

局限性

  • 原文未报告局限性。

以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。

原文

PURPOSE: Anoikis is a special apoptosis accompanied by the loss of extracellular matrix (ECM) environment and the decomposition of ECM is an important process in the occurrence of keratoconus (KC). This study aims to describe the expression profile of anoikis-related genes (ARGs) in KC samples, identify differentially expressed genes (DEGs), characterize the biological functions and immune characteristics of different molecular subtypes of KC and predict potential drugs based on the construction of a co-expression network. METHODS: First, we identified molecular subtypes by optimal clustering K based on the expression profile of ARGs in the KC dataset and analyzed the differences of functional and immune characteristics. Then a weighted gene co-expression network was constructed based on cluster analysis to obtain hub genes and protein-protein interaction network was constructed to analyze hub nodes and predict potential node-targeting drugs. RESULTS: By comparing the expression profile between disease and normal samples, we found that there were significant differences in ARGs such as BCL2, CAV1, and CEACAM5. Consistent cluster analysis identified two definite clusters on the basis of ARGs expression difference. Kyoto Encyclopedia of Genes and Genomes and Gene Ontology enrichment analysis showed that DEGs were enriched significantly in pathways like ECM receptor interaction, chemokine signal, notch signal, focal adhesion, and functional sets like proteolysis, anoikis, regulation of natural killer and T-cell proliferation. CIBERSORT calculation showed that there were significant differences between the two subtypes on immune cell infiltration (monocytes and plasma) and immune molecules (CCL11, CCL14, HLA-A, HLA-B, and so on). Then, co-expression network was constructed based on cluster phenotype, 5202 genes were selected as hub genes, and 321 HubDEGs were obtained after intersection with significant DEGs. Seven hub nodes, EIF4G1, KHSRP, PABPC1, POLR2A, PTBP1, RPS19, and SMARCA4, were identified and matched drugs or small molecular compounds. Insulin and dexamethasone were identified as potential target drugs. CONCLUSIONS: We revealed the differential expression of ARGs in KC samples, and identified two distinct subtypes that showed significant differences in biological function and immune infiltration. The identification of hub gene nodes elucidated their therapeutic value on predicted potential drugs.

来源:Invest Ophthalmol Vis Sci,查看原文。版权归原作者所有。

引用

  1. Jiang Z, Zhang B, Jia S, et al. Molecular Subtype Identification and Potential Drug Prediction Based on Anoikis-Related Genes Expression in Keratoconus. Invest Ophthalmol Vis Sci. 2025. PMID: 39898909. doi:10.1167/iovs.66.2.3

供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。